2024 annual financial data
Immuneering 2024 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -64,071,401 USD and net income was -61,036,608 USD.
Operating cash flow was -54,999,571 USD.
Get free Immuneering email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -64,071,401 USD
- Net income
- -61,036,608 USD
- Operating cash flow
- -54,999,571 USD